Recent Advances in Vaccines and Drugs Against the Ebola Virus / 病毒学报
Chinese Journal of Virology
; (6): 287-292, 2015.
Article
in Zh
| WPRIM
| ID: wpr-296286
Responsible library:
WPRO
ABSTRACT
The Ebola virus belongs to the Filovirus family, which causes Ebola hemorrhagic fever (mortality, 25%-90%). An outbreak of infection by the Ebola virus is sweeping across West Africa, leading to high mortality and worldwide panic. The Ebola virus has caused a serious threat to public health, so intensive scientific studies have been carried out. Several vaccines (e.g., rVSV-ZEBOV, ChAd3-ZEBOV) have been put into clinical trials and antiviral drugs (e.g., TKM-Ebola, ZMAPP) have been administered in the emergency setting to patients infected by the Ebola virus. Here, recent advances in vaccines and drugs against the Ebola virus are reviewed.
Full text:
1
Index:
WPRIM
Main subject:
Antiviral Agents
/
Physiology
/
Virology
/
Hemorrhagic Fever, Ebola
/
Ebola Vaccines
/
Drug Therapy
/
Ebolavirus
/
Allergy and Immunology
/
Genetics
Limits:
Animals
/
Humans
Language:
Zh
Journal:
Chinese Journal of Virology
Year:
2015
Type:
Article